 |
|
Two suppressor molecules affect 70 genes in leukemia
April 25, 2008COLUMBUS, Ohio - By restoring two small molecules that are often lost in chronic leukemia, researchers were able to block tumor growth in an animal model.
The research, using human chronic lymphocytic leukemia (CLL) cells, also showed that loss of the two molecules affects 70 genes, most of which are involved in critical functions such as cell growth, death, proliferation and metabolism.
The findings reveal how the two molecules, called miR-15a and miR-16-1, normally protect against cancer, and suggest a possible new treatment strategy for CLL.
The study, led by researchers at the Ohio State University Comprehensive Cancer Center, was published recently in the Proceedings of the National Academy of Sciences.
"These findings give us a signature of 70 deregulated genes that we believe finally explains at the molecular level how these two molecules contribute to CLL," says principal investigator Carlo M. Croce, director of Ohio State's human cancer genetics program.
"The identification of these genes could also have important significance for the development of new therapeutic approaches for chronic leukemias."
The two molecules are forms of microRNA, tiny molecules that cells use to help regulate the type and amount of proteins they make.
In 2005, Croce and his colleagues first showed that these two microRNAs target a gene called Bcl2, which normally helps cells survive by protecting them from accidental self-destruction. In CLL, however, the gene behaves abnormally and helps the leukemic cells survive long after they should have died.
Croce and his colleagues believe that loss of the two molecules alters the gene's behavior.
For the new study, the investigators first injected mice with leukemia cells in which they had restored the two microRNAs. This completely suppressed tumor growth in three of five animals. Mice injected with leukemic cells that lacked the two molecules, on the other hand, developed significant tumors.
"This clearly showed that these two microRNAs can suppress tumor development," says coauthor Muller Fabrri, a researcher in Croce's laboratory.
Because each microRNA regulates many genes, the investigators wanted to learn which ones, in addition to Bcl2, are affected in cells lacking the two molecules.
First, they measured differences in gene activity in laboratory-grown CLL cells that had either high or low levels of the two molecules.
Next, they measured the levels of all the proteins in the two groups of cells. This proteomic analysis revealed 27 proteins with highly altered amounts. These were identified and shown to be involved in cell growth, cell death and cancer development.
Last, the researchers used human CLL cells from 16 patients to verify the gene targets.
"Together, these extensive experiments revealed the signature of 70 genes controlled by the two microRNAs," Fabbri says. "They show that microRNAs can affect different biochemical pathways in different ways, and they explain at the molecular level what these two miRNAs do in this disease."
Ohio State University Medical Center
The study, led by researchers at the Ohio State University Comprehensive Cancer Center, was published recently in the Proceedings of the National Academy of Sciences.
"These findings give us a signature of 70 deregulated genes that we believe finally explains at the molecular level how these two molecules contribute to CLL," says principal investigator Carlo M. Croce, director of Ohio State's human cancer genetics program.
"The identification of these genes could also have important significance for the development of new therapeutic approaches for chronic leukemias."
The two molecules are forms of microRNA, tiny molecules that cells use to help regulate the type and amount of proteins they make.
In 2005, Croce and his colleagues first showed that these two microRNAs target a gene called Bcl2, which normally helps cells survive by protecting them from accidental self-destruction. In CLL, however, the gene behaves abnormally and helps the leukemic cells survive long after they should have died.
Croce and his colleagues believe that loss of the two molecules alters the gene's behavior.
For the new study, the investigators first injected mice with leukemia cells in which they had restored the two microRNAs. This completely suppressed tumor growth in three of five animals. Mice injected with leukemic cells that lacked the two molecules, on the other hand, developed significant tumors.
"This clearly showed that these two microRNAs can suppress tumor development," says coauthor Muller Fabrri, a researcher in Croce's laboratory.
Because each microRNA regulates many genes, the investigators wanted to learn which ones, in addition to Bcl2, are affected in cells lacking the two molecules.
First, they measured differences in gene activity in laboratory-grown CLL cells that had either high or low levels of the two molecules.
Next, they measured the levels of all the proteins in the two groups of cells. This proteomic analysis revealed 27 proteins with highly altered amounts. These were identified and shown to be involved in cell growth, cell death and cancer development.
Last, the researchers used human CLL cells from 16 patients to verify the gene targets.
"Together, these extensive experiments revealed the signature of 70 genes controlled by the two microRNAs," Fabbri says. "They show that microRNAs can affect different biochemical pathways in different ways, and they explain at the molecular level what these two miRNAs do in this disease."
Ohio State University Medical Center
Leukemia News and Current Leukemia Events RSSVCU Massey Cancer Center Spearheads Novel Clinical Study for Lymphoma Patients
The Virginia Commonwealth University Massey Cancer Center recently opened a National Cancer Institute (NCI)-sponsored, phase II clinical study for certain sub-types of non-Hodgkin's lymphoma.
New insights into the regulation of PTEN tumor suppression function
The PTEN tumor suppressor gene controls numerous biological processes including cell proliferation, cell growth and death. But PTEN is frequently lost or mutated; in fact, alteration of the gene is so common among various types of human cancer that PTEN has become one of the most frequently mutated of all tumor suppressors.
Children's national co-leads nationwide study of landmark sickle cell treatment
Children's National Medical Center immunologist and blood and marrow transplant physician Naynesh Kamani, MD, will serve as the study co-chair for a new national clinical trial of unrelated donor marrow and umbilical cord blood transplants for severe sickle cell disease.
Newly discovered molecular switch helps decide cell type in early embryo development
Researchers have discovered a central molecular switch in fruit fly embryos that opens new avenues for studying the causes of birth defects and cancer in humans. Writing about their study in the Aug. 12 Developmental Cell, scientists at Cincinnati Children's Hospital Medical Center determined the switch to be a main tuning mechanism for instructing cells whether to form sensory nerves or blood cells in different parts of the body.
McGill researchers overcome chemotherapy resistance in the lab
Researchers from McGill University's Faculty of Medicine have discovered a compound that reduces resistance to chemotherapy agents used to treat cancer. Their results were published in the June issue of The Journal of Clinical Investigation (JCI).
Crucial Factors in Lymphoma Development and Survival Discovered
Researchers at National Jewish Medical and Research Center have discovered an important factor in the development of B-cell lymphomas, one of the fastest growing forms of cancer.
Leukemia drug could save lives of stroke patients
The drug tPA is the most effective treatment currently available for stroke patients, but its safety is limited to use within the first three hours following the onset of symptoms.
Stroke study reveals key target for improving treatment and suggests that Gleevec may help
For over a decade, the drug called tPA has proven its worth as the most effective emergency treatment for the most common kind of stroke. But its promise is blemished by two facts: tPA can cause dangerous bleeding in the brain, and its brain-saving power fades fast after the third hour of a stroke.
Math could help cure leukemia
When kids complain that math homework won't help them in real life, a new answer might be that math could help cure cancer.
Combining math and medicine to treat leukemia
Researchers have produced a mathematical model that may lead to the development of an optimally-timed vaccine for chronic myelogenous leukemia (CML).
More Leukemia News Articles
 | My Sister's Keeper: A Novel by Jodi Picoult New York Times bestselling author Jodi Picoult is widely acclaimed for her keen insights into the hearts and minds of real people. Now she tells the emotionally riveting story of a family torn apart by conflicting needs and a passionate love that triumphs over human weakness.Anna is not sick, but she might as well be. By age thirteen, she has undergone countless surgeries, transfusions, and shots... |
 | Drums, Girls, And Dangerous Pie by Jordan Sonnenblick Thirteen-year-old Steven has a totally normal life: he plays drums in the All-Star Jazz band, has a crush on the hottest girl in the school, and is constantly annoyed by his five-year-old brother, Jeffrey. But when Jeffrey is diagnosed with leukemia, Steven's world is turned upside down. He is forced to deal with his brother's illness and his parents' attempts to keep the family in one piece.... |
 | Sadako and the Thousand Paper Cranes (PMC) (Puffin Modern Classics) by Eleanor Coerr Born in Hiroshima in 1943, Sadako was the star of her school’s running team, until the dizzy spells started and she was forced to face the hardest race of her life—the race against... |
 | It's Only Temporary: The Good News and the Bad News of Being Alive by Evan Handler A provocative, funny, and whip- smart memoir of how one man learned to find joy in his own life after years of hand-to-hand combat with death. Actor and author Evan Handler’s new book, It’s Only Temporary, is both a deeply personal memoir and a series of meditations on life, love, faith, gratitude, and mortality. In closely examining his own triumphs, mistakes, and less-than-ideal relationships... |
 | The Rainmaker by John Grisham Michael Beck (The Golden Seal, Xanadu), who seems to be making a career out of reading books on audio (A Time to Kill, The Runaway Jury), has returned with John Grisham's The Rainmaker, bringing the backwoods of Tennessee's legal world to life. His sultry, southern drawl animates the world of Rudy Baylor, an out-of-luck, budding lawyer who has more things going against him than bedraggled, ... |
 | The Breuss Cancer Cure: Advice for the Prevention and Natural Treatment of Cancer, Leukemia and Other Seemingly Incurable Diseases by Rudolf Breuss |
 | Gideon's Gift (The Red Gloves Collection #1) by Karen Kingsbury One long-ago Christmas, Big Earl Gibson lost the two things most precious to him-his wife and daughter. Angry and heartbroken, he abandoned his belief in God and is now living on the street. Gideon is a seven-year-old leukemia patient determined to reach out to this lonely and hurting man. And Earl is just as determined to rebuff her. It is only through a miracle that Earl finally comes to... |
 | Sadako by Eleanor Coerr |
 | Childhood Leukemia: A Guide for Families, Friends and Caregivers (3rd Edition) by Nancy Keene This most complete parent guide covers not only detailed and precise medical information about leukemia and the various treatment options, but also day-to-day practical advice on how to cope with procedures, hospitalization, family and friends, school, social and financial issues, communication, feelings, and, if therapy is not successful, the difficult issues of death and bereavement. Woven... |
 | The Christmas Spurs by Bill Wallace When you're a big brother you don't cry, no matter how scared you are. And I'm scared. My little brother, Jimmy, is sick. All I want for Christmas is for him to get well. Santa seems to be listening when we get Buck, the best horse ever! I get spurs, and Jimmy gets a new cowboy hat, a real Stetson. He's so happy it almost makes us forget...untilJimmy's in the hospital again. I try to act big and... |
| © 2008 BrightSurf.com |